Chauhan Shubham, Shinu Pottathil, Kaur Narinder, Saini Adesh K, Bala Rosy, Nair Anroop B, Rahman Aminur, Morsy Mohamed A
Department of Microbiology, Maharishi Marksandeshwar Institute of Medical Science and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, India.
Department of Biomedical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi Arabia.
Pol J Microbiol. 2025 Mar 26;74(1):95-105. doi: 10.33073/pjm-2025-008. eCollection 2025 Mar 1.
Antimicrobial resistance poses a significant threat to global health, with colistin as a last-resort antibiotic against multidrug-resistant (MDR) microorganisms. The present study aimed to investigate the dynamics of antimicrobial susceptibility patterns and risk factors associated with infections caused by colistin-resistant bacteria in the Northern region of Haryana, India. Clinical samples (n = 12,652) collected from a single hospital in Haryana were subjected to microbiological analysis for five months. Among the total samples (n = 12,652) processed, 24% (n = 3,061) showed growth of pathogenic bacteria. Within the Gram-negative isolates, 56% (n = 1,242) were non-MDR, while 44% (n = 995) were MDR. Among MDR isolates (n = 995), 6% (n = 57) showed resistance to colistin. Notably, spp. (12%, n = 19) and spp. (11%, n = 8) demonstrated the highest resistance to colistin, followed by spp. (5%, n = 13), (3%, n = 16), and (1%, n = 1), respectively. The study revealed significant associations between the level of education (demographic variable) and the occurrence of colistin resistance. Prolonged hospital stays (> 5 days) and specific comorbidities, including diabetes ( < 0.01) and chronic obstructive pulmonary disease ( < 0.01), were identified as risk factors for colistin-resistant infections. Importantly, none of the colistin-resistant bacteria harbored genes, suggesting alternative resistance mechanisms. Antibiotic sensitivity analysis indicated promising efficacy of antibiotics such as amikacin and gentamicin against colistin-resistant strains, though with variations across bacterial species. In summary, the study emphasizes the urgent need for enhanced surveillance, infection control protocols, and antimicrobial stewardship programs in healthcare settings to minimize the dissemination of MDR and colistin-resistant bacteria.
抗菌药物耐药性对全球健康构成重大威胁,黏菌素是对抗多重耐药(MDR)微生物的最后一道抗生素防线。本研究旨在调查印度哈里亚纳邦北部地区耐黏菌素细菌引起感染的抗菌药物敏感性模式动态及相关危险因素。从哈里亚纳邦一家医院收集的12652份临床样本进行了为期五个月的微生物学分析。在总共处理的样本(n = 12652)中,24%(n = 3061)显示有病原菌生长。在革兰氏阴性菌分离株中,56%(n = 1242)为非MDR,而44%(n = 995)为MDR。在MDR分离株(n = 995)中,6%(n = 57)对黏菌素耐药。值得注意的是, spp.(12%,n = 19)和 spp.(11%,n = 8)对黏菌素的耐药性最高,其次分别是 spp.(5%,n = 13)、 (3%,n = 16)和 (1%,n = 1)。该研究揭示了教育水平(人口统计学变量)与黏菌素耐药性发生之间的显著关联。住院时间延长(>5天)和特定合并症,包括糖尿病(<0.01)和慢性阻塞性肺疾病(<0.01),被确定为耐黏菌素感染的危险因素。重要的是,没有一株耐黏菌素细菌携带 基因,这表明存在其他耐药机制。抗生素敏感性分析表明,阿米卡星和庆大霉素等抗生素对耐黏菌素菌株有良好疗效,尽管不同细菌种类存在差异。总之,该研究强调在医疗机构中迫切需要加强监测、感染控制方案和抗菌药物管理计划,以尽量减少MDR和耐黏菌素细菌的传播。